FI924744L - Terapeutiska aemnen - Google Patents

Terapeutiska aemnen Download PDF

Info

Publication number
FI924744L
FI924744L FI924744A FI924744A FI924744L FI 924744 L FI924744 L FI 924744L FI 924744 A FI924744 A FI 924744A FI 924744 A FI924744 A FI 924744A FI 924744 L FI924744 L FI 924744L
Authority
FI
Finland
Prior art keywords
therapeutic
present
therapeutic present
Prior art date
Application number
FI924744A
Other languages
English (en)
Finnish (fi)
Other versions
FI924744A0 (fi
FI924744A7 (fi
Inventor
Cyrus John Ohnmacht
Original Assignee
Ici Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB919122305A external-priority patent/GB9122305D0/en
Priority claimed from GB929213538A external-priority patent/GB9213538D0/en
Application filed by Ici Plc filed Critical Ici Plc
Publication of FI924744A0 publication Critical patent/FI924744A0/fi
Publication of FI924744A7 publication Critical patent/FI924744A7/fi
Publication of FI924744L publication Critical patent/FI924744L/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/06Anti-spasmodics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/10Drugs for disorders of the urinary system of the bladder
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D219/00Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
    • C07D219/04Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • C07D219/06Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FI924744A 1991-10-21 1992-10-20 Terapeutiska aemnen FI924744L (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB919122305A GB9122305D0 (en) 1991-10-21 1991-10-21 Therapeutic agents
GB929213538A GB9213538D0 (en) 1992-06-25 1992-06-25 Therapeutic agent

Publications (3)

Publication Number Publication Date
FI924744A0 FI924744A0 (fi) 1992-10-20
FI924744A7 FI924744A7 (fi) 1993-04-22
FI924744L true FI924744L (fi) 1993-04-22

Family

ID=26299722

Family Applications (1)

Application Number Title Priority Date Filing Date
FI924744A FI924744L (fi) 1991-10-21 1992-10-20 Terapeutiska aemnen

Country Status (18)

Country Link
US (1) US5258390A (de)
EP (1) EP0539153B1 (de)
JP (1) JP3157924B2 (de)
KR (1) KR930007907A (de)
AT (1) ATE152103T1 (de)
AU (1) AU659500B2 (de)
CA (1) CA2080950A1 (de)
CZ (1) CZ317592A3 (de)
DE (2) DE69219271T2 (de)
FI (1) FI924744L (de)
GB (1) GB9220570D0 (de)
HU (1) HUT65626A (de)
IL (1) IL103478A0 (de)
MY (1) MY106661A (de)
NO (1) NO178696C (de)
NZ (1) NZ244822A (de)
PL (1) PL169716B1 (de)
TW (1) TW223061B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9214120D0 (en) * 1991-07-25 1992-08-12 Ici Plc Therapeutic amides
EP0539154B1 (de) 1991-10-21 1997-12-29 Zeneca Limited Acridine-1,8-Dionderivate als therapeutisches Mittel
US5455253A (en) * 1992-10-20 1995-10-03 Zeneca Limited Heterocyclic derivatives
GB9318935D0 (en) * 1992-10-20 1993-10-27 Zeneca Ltd Heterocyclic derivatives
GB9310069D0 (en) * 1993-05-17 1993-06-30 Zeneca Ltd Heterocyclic compounds
GB9407432D0 (en) * 1994-04-14 1994-06-08 Zeneca Ltd Heterocyclic derivative
AU5090796A (en) 1995-03-03 1996-09-23 Algos Pharmaceutical Corporation Use of dextromethorphan or dextrorphan for the treatment of urinary incontinence
GB9707695D0 (en) * 1996-08-07 1997-06-04 Hoffmann La Roche Tricyclic dione derivatives
US7030096B1 (en) * 1997-02-13 2006-04-18 Albert Einstein College Of Medicine Of Yeshiva University Method of enhancing relaxation of penile smooth muscle by introduction of DNA encoding maxi-K potassium channel protein
AU1459500A (en) * 1998-10-28 2000-05-15 Abbott Laboratories Dihydropyridine compounds and methods of use
US6642222B2 (en) 1998-10-28 2003-11-04 Abbott Laboratories Pyrano, piperidino, and thiopyrano compounds and methods of use
US6191140B1 (en) * 1998-10-28 2001-02-20 Abbott Laboratories Pyrano, piperidino, and thiopyrano compounds and methods of use
US6518279B2 (en) 1999-03-04 2003-02-11 Abbott Laboratories Cyclopentanone dihydropyridine compounds useful as potassium channel openers
US6348486B1 (en) * 2000-10-17 2002-02-19 American Home Products Corporation Methods for modulating bladder function
US20020183395A1 (en) 2001-04-04 2002-12-05 Wyeth Methods for treating hyperactive gastric motility
EP1688141A1 (de) 2005-01-31 2006-08-09 elbion AG Verwendung von Flupirtine zur Behandlung der hyperaktiven Blase und damit zusammenhängender Erkrankungen und zur Behandlung des Reizdarmsyndroms
WO2006133193A1 (en) * 2005-06-07 2006-12-14 American Medical Systems Research Corporation Injection guidance system and method
AU2007215005A1 (en) 2006-02-10 2007-08-23 Janssen Pharmaceutica N.V. Novel tricyclic dihydropyrazines as potassium channel openers

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3454577A (en) * 1965-11-09 1969-07-08 Hoffmann La Roche 4-(1,2,3,4,5,6,7,8 - octahydro - 1,8 - dioxo-9-acridanyl) - benzenesulfonamide and derivatives
DE2003148A1 (de) 1970-01-24 1971-07-29 Bayer Ag Neue 1,4-Dihydropyridinderivate
DE2018738A1 (en) * 1970-04-18 1971-10-28 Farbenfabriken Bayer Ag, 5090 Leverkusen Hydrogenated pyridines, quinolines andacridi
US4021434A (en) * 1972-01-22 1977-05-03 Yamanouchi Pharmaceutical Co., Ltd. Sodium β-[2,6-dimethyl-3,5-bis(ethoxycarbonyl)-4-(3-nitrophenyl)-1,4-dihydropyridine-1-yl]ethyl sulfate
DE2242106A1 (de) * 1972-08-26 1974-03-21 Agfa Gevaert Ag Lichtempfindliches photographisches material
DE2718130C2 (de) * 1977-04-23 1979-05-17 Du Pont De Nemours (Deutschland) Gmbh, 4000 Duesseldorf lichtempfindliches Aufzeichnungsmaterial
US4546186A (en) * 1983-12-14 1985-10-08 American Home Products Corporation 1,4,5,6,7,8-Hexahydro-2-methyl-5-oxo-4-(2-thiazolyl)-3-quinoline carboxylic acid 2-methyl(phenylmethyl)amino ethyl ester and pharmaceutically acceptable salts

Also Published As

Publication number Publication date
PL169716B1 (pl) 1996-08-30
GB9220570D0 (en) 1992-11-11
CZ317592A3 (en) 1993-05-12
FI924744A0 (fi) 1992-10-20
DE69219271T2 (de) 1997-08-07
JP3157924B2 (ja) 2001-04-23
HU9203288D0 (en) 1992-12-28
AU2713992A (en) 1993-04-22
NZ244822A (en) 1994-10-26
MY106661A (en) 1995-07-31
JPH05201986A (ja) 1993-08-10
DE69219271D1 (de) 1997-05-28
DE69223736D1 (de) 1998-02-05
NO924066L (no) 1993-04-22
CA2080950A1 (en) 1993-04-22
AU659500B2 (en) 1995-05-18
ATE152103T1 (de) 1997-05-15
NO924066D0 (no) 1992-10-20
EP0539153A1 (de) 1993-04-28
EP0539153B1 (de) 1997-04-23
FI924744A7 (fi) 1993-04-22
NO178696C (no) 1996-05-15
PL296229A1 (en) 1993-10-04
KR930007907A (ko) 1993-05-20
DE69223736T2 (de) 1998-05-07
HUT65626A (en) 1994-07-28
IL103478A0 (en) 1993-03-15
NO178696B (no) 1996-02-05
US5258390A (en) 1993-11-02
TW223061B (en) 1994-05-01

Similar Documents

Publication Publication Date Title
FI923379L (fi) Terapeutiska amider
FI934964L (fi) Teraupetiskt aemne
FI935878L (fi) Porfycenfoereningar foer fotodynamisk terapi
FI943018A7 (fi) Terapeuttisia aineita
FI922785A7 (fi) Terapeuttisia valmisteita
ATE137279T1 (de) Stoffauflauf
FI924069L (fi) Terapeutiskt anvaendbara peptider och peptidfragment
FI924456L (fi) Laekemedel
FI934189A7 (fi) Transdermalt terapeutiskt plaoster
DK0507513T3 (da) Terapeutisk anordning
ATA131391A (de) Reibring
FI924744L (fi) Terapeutiska aemnen
FI922238A7 (fi) Stoed foer terapeutisk magnet
FI923663A7 (fi) Terapeutiska foereningar
FI943020A7 (fi) Terapeuttisia aineita
FI923759L (fi) Terapeutiska bensazapinfoereningar
FI930674L (fi) Terapeutiska aemnen
FI923662A7 (fi) Terapeuttisia aineita
PT100435A (pt) Nucleosidos terapeuticos
DK56591D0 (da) Toerringsfremgangsmaade
ATA170491A (de) Mauerstein
ATA39792A (de) Maehwerk
FI931071L (fi) Terapeutiska aemnen
ATE163916T1 (de) Ethyl-6-formyloxy-4-hexenoat
FI920701L (fi) Anordning foer terapeutisk tryckbehandling

Legal Events

Date Code Title Description
FD Application lapsed